Evidence map›Paper›PMID 35779780›Full record

ArticleThe journal of allergy and clinical immunology. In practice2022

Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.

Julia R Hirsiger, Sebastian Weigang, Antje-Christine Walz, Jonas Fuchs, Mary-Louise Daly, Stefan Eggimann, Oliver Hausmann, Martin Schwemmle, Georg Kochs, Marcus Panning and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Julia R HirsigerTranslational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Sebastian WeigangInstitute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Antje-Christine WalzRoche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
Jonas FuchsInstitute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Mary-Louise DalyUniversity Center for Immunology, University Hospital Basel, Basel, Switzerland.
Stefan EggimannSwiss Society for Inborn Errors of Immunity, Zurich, Switzerland.
Oliver HausmannADR-AC GmbH, Adverse Drug Reactions-Analysis and Consulting, Bern, Switzerland; Löwenpraxis Luzern und Klinik St Anna, Lucerne, Switzerland.
Martin SchwemmleInstitute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Georg KochsInstitute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Marcus PanningInstitute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Klaus WarnatzDepartment of Rheumatology and Clinical Immunology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Mike RecherUniversity Center for Immunology, University Hospital Basel, Basel, Switzerland; Immunodeficiency Lab, Department Biomedicine, University of Basel, Basel, Switzerland.
Christoph T BergerTranslational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland; University Center for Immunology, University Hospital Basel, Basel, Switzerland. Electronic address: christoph.berger@usb.ch.
University of Freiburg · DEUniversity of Basel · CHADR-AC (Switzerland) · CHRoche (Switzerland) · CHUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, ViralHumansImmunization, PassiveImmunoglobulin GAntibodies, ViralImmunoglobulin G

Identifiers

PMID35779780
PMCPMC9239915
OpenAlexW4283707054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.